Intellia Therapeutics (NTLA) PT Raised to $20 at Wedbush, Following Business Update
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $20.76 +3.70%
Rating Summary:
27 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 22 | Down: 21 | New: 11
Rating Summary:
27 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 22 | Down: 21 | New: 11
Join SI Premium – FREE
Wedbush analyst David Nierengarten raised the price target on Intellia Therapeutics (NASDAQ: NTLA) to $20.00 (from $16.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CIBC Downgrades Celestica (CLS) to Neutral
- JPMorgan Downgrades Nari Tech (600406:CH) to Neutral
- Svenska Handelsbanken AB (SHBA:SS) (SVNLY) PT Lowered to SEK105 at CFRA
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
